1. Home
  2. OZK vs TGTX Comparison

OZK vs TGTX Comparison

Compare OZK & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OZK
  • TGTX
  • Stock Information
  • Founded
  • OZK 1903
  • TGTX 1993
  • Country
  • OZK United States
  • TGTX United States
  • Employees
  • OZK N/A
  • TGTX N/A
  • Industry
  • OZK Major Banks
  • TGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OZK Finance
  • TGTX Health Care
  • Exchange
  • OZK Nasdaq
  • TGTX Nasdaq
  • Market Cap
  • OZK 5.7B
  • TGTX 5.4B
  • IPO Year
  • OZK 1997
  • TGTX 1995
  • Fundamental
  • Price
  • OZK $43.83
  • TGTX $32.20
  • Analyst Decision
  • OZK Hold
  • TGTX Strong Buy
  • Analyst Count
  • OZK 11
  • TGTX 6
  • Target Price
  • OZK $49.22
  • TGTX $40.67
  • AVG Volume (30 Days)
  • OZK 1.1M
  • TGTX 2.2M
  • Earning Date
  • OZK 01-16-2025
  • TGTX 11-04-2024
  • Dividend Yield
  • OZK 3.74%
  • TGTX N/A
  • EPS Growth
  • OZK 6.42
  • TGTX N/A
  • EPS
  • OZK 6.08
  • TGTX N/A
  • Revenue
  • OZK $1,459,235,000.00
  • TGTX $264,790,000.00
  • Revenue This Year
  • OZK N/A
  • TGTX $43.74
  • Revenue Next Year
  • OZK $0.42
  • TGTX $64.30
  • P/E Ratio
  • OZK $7.21
  • TGTX N/A
  • Revenue Growth
  • OZK 9.32
  • TGTX 39.53
  • 52 Week Low
  • OZK $37.43
  • TGTX $12.84
  • 52 Week High
  • OZK $51.50
  • TGTX $36.84
  • Technical
  • Relative Strength Index (RSI)
  • OZK 34.74
  • TGTX 51.73
  • Support Level
  • OZK $43.21
  • TGTX $30.41
  • Resistance Level
  • OZK $47.76
  • TGTX $35.03
  • Average True Range (ATR)
  • OZK 1.35
  • TGTX 1.80
  • MACD
  • OZK -0.63
  • TGTX -0.46
  • Stochastic Oscillator
  • OZK 10.78
  • TGTX 35.31

About OZK Bank OZK

Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit and individual retirement accounts to loan services like real estate, consumer, commercial and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking and other related services.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). and the company is developing TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders which are under Phase 1 trial.

Share on Social Networks: